Related Experiment Video

Updated: Aug 13, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD

A F Baas1, J Boudeau, G P Sapkota

  • 1Hubrecht Laboratory, Centre for Biomedical Genetics, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.

The EMBO Journal
|June 14, 2003
PubMed

Insights

Researchers identified STRAD, an LKB1 adaptor protein crucial for tumor suppression. STRAD activates LKB1 kinase, regulates its cellular location, and is essential for LKB1

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The LKB1 gene is a serine/threonine kinase implicated in Peutz-Jeghers cancer syndrome.
  • The precise molecular mechanisms underlying LKB1's roles in development and tumor suppression are not fully understood.

Purpose of the Study:

  • To identify and characterize novel proteins interacting with LKB1.
  • To elucidate the role of these interactions in LKB1's function and regulation.

Main Methods:

  • Protein complex identification and characterization.
  • Kinase activity assays.
  • Subcellular localization studies using wild-type and mutant LKB1.
  • RNA interference (siRNA) to deplete STRAD.
  • Cell cycle arrest analysis.

Main Results:

  • Identification of STRAD (STe20 Related ADaptor), an LKB1-specific adaptor protein and substrate.
  • STRAD activates LKB1 kinase activity and promotes phosphorylation of both proteins.
  • STRAD mediates the nuclear-to-cytoplasmic translocation of wild-type LKB1.
  • A Peutz-Jeghers-associated LKB1 mutation disrupts STRAD binding and STRAD-dependent regulation.
  • siRNA-mediated depletion of STRAD abolishes LKB1-induced G(1) cell cycle arrest.

Conclusions:

  • STRAD is a key regulator of LKB1 activity and function.
  • STRAD's interaction with LKB1 is critical for LKB1's tumor suppressor activities.
  • Dysregulation of the LKB1-STRAD interaction may contribute to Peutz-Jeghers cancer syndrome.

More Related Videos

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein11:23

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein

Published on: June 30, 2019

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...